The role of cytokines in prostatitis

World Journal of Urology

Volumn 21, Issue 2, 2003, Pages 95-99

  Jang, Thomas L ^a   Schaeffer, Anthony J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Chronic pelvic pain syndrome; Chronic prostatitis; Cytokines; Infection; Inflammation

Indexed keywords

CYTOKINE;

BIOSYNTHESIS; CHRONIC DISEASE; GENETICS; HUMAN; IMMUNOLOGY; MALE; PATHOPHYSIOLOGY; PELVIS PAIN SYNDROME; PROSTATITIS; REVIEW;

CHRONIC DISEASE; CYTOKINES; HUMANS; MALE; PELVIC PAIN; PROSTATITIS;

EID: 0642308366     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-003-0335-2     Document Type: Conference Paper

References (38)

1. Alexander RB (2001) Immunology and prostatitis, from highlights of the third annual International Prostatitis Collaborative Network Meeting. Rev Urol 3:95-96
2. Alexander RB, Trissel D (1996) Chronic prostatitis: results of an Internet survey. Urology 48:568-574
3. Alexander RB, Ponniah S, Hasday J, Hebel JR (1998) Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome. Urology 52:744-749
4. Arai K, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T (1990) Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem 59:783-836
5. Baert FJ, D'Haens GR, Peeters M (1999) Tumor necrosis factor alpha antibody (infliximab) therapy profoundly downregulates the inflammation in Crohn's ileocolitis. Gastroenterology 116:22-28
6. Baggiolini M, Walz A, Kunkel SL (1989) Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84:1045-1049
7. Charles P, Elliott MJ, Davis D (1999) Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis. J Immunol 163:1521-1528
8. Collins MM, O'Leary MP, Litwin MS, Calhoun EA, Kusek JW, Santanna J, Landis JR (2000) Quality of life is impaired in men with chronic prostatitis: results from the NIH cohort study. J Urol 163 (Suppl):23
9. Collins MM, Stafford RS, O'Leary MP, Barry MJ (1998) How common is prostatitis? A national survey of physician visits. J Urol 159:1224-1228
10. De la Rosette JJ, Hubregtse MR, Meuleman EJ, Stolk-Engelaar MV, Debruyne FM (1993) Diagnosis and treatment of 409 patients with prostatitis syndromes. Urology 41:301-307
11. Dinarello CA (2000) Proinflammatory cytokines. Chest 118:503-508
12. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S (1998) The effect of novel polymorphisms in the IL-6 gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102:1369
13. 2 synthesis and metabolism in burn injury and trauma. J Trauma 49:1147-1154
14. Halloran MM, Woods JM, Strieter RM (1999) The role of an epithelial neutrophil-activating peptide-78-like protein in rat adjuvant-induced arthritis. J Immunol 162:7492-7500
15. Hochreiter WW, Nadler RB, Koch AE, Campbell PL, Ludwig M, Weidner W, Schaeffer AJ (2000) Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. Urology 56:1025-1029
16. Kaijzel EL, Brinkman BM, van Krugten MV, Smith L, Huizinga TW, Verjans GM (1999) Polymorphism within the tumor necrosis factor alpha promoter region in patients with ankylosing spondylitis. Hum Immunol 60:140
17. Koch AE, Kunkel SL, Harlow LA (1994) Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis. J Clin Invest 94:1012-1018
18. Kornman KS, Pankow J, Offenbacher S, Beck J, diGiovine, F, Duff GW (1999) Interleukin-1 genotypes and the association between periodontitis and cardiovascular disease. J Periodontal Res 34:353
19. Koss K, Satsangi J, Fanning GC, Welsh KI, Jewell DP (2000) Cytokine (TNF-alpha, LT-alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies. Genes Immun 1:185
20. Litwin MS, Collins MM, Fowler FJ, Nickel JC, Calhoun EA, Pontari MA (1999) The National Institutes of Health Chronic Prostatitis Symptom Index: development and validation of a new outcome measure. J Urol 162:369-375
21. Miller LJ, Fischer KA, Goralnick SJ, Litt M, Burleson JA, Albertsen P, Kreutzer DL (2002) Interleukin-10 levels in seminal plasma: implications for chronic prostatitis-chronic pelvic pain syndrome. J Urol 167:753-756
22. Mitchell SA, Grove J, Spurkland A, Boberg KM, Fleming KA, Day CP (2001) Association of the tumour necrosis factor alpha-308 but not the interleukin 10-627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis. Gut 49:288
23. Moffatt MF, Cookson WO (1997) Tumour necrosis factor haplotypes and asthma. Hum Mol Genet 6:551
24. National Kidney and Urologic Diseases Advisory Board (1990) Long-range plan window in the 21st century. United States Department of Health and Human Services, National Institutes of Health and Human Services, National Institutes of Health, Bethesda
25. Nadler RB, Koch AE, Calhoun EA, Campbell PL, Pruden DL, Bennett CL, Yarnold PR, Schaeffer AJ (2000) IL-1-[beta] and TNF-[alpha] in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol 164:214-218
26. Nickel JC (2002) Prostatitis and related conditions. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ (eds) Campbell's urology, vol 1. Saunders, Philadelphia, pp 603-630
27. Nickel JC, Nyberg LM, Hennenfent M, International Prostatitis Collaborative Network (1999) Research guidelines for chronic prostatitis: consensus report from the first National Institutes of Health International Prostatitis Collaborative Network. Urology 54:229-233
28. Norman J (1998) The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg 175:76-83
29. Opal, SM, DePalo VA (2000) Anti-inflammatory cytokines. Chest 117:1162-1172
30. Raeburn CD, Sheppard F, Barsness KA, Arya J, Harken AH (2002) Cytokines for surgeons. Am J Surg 183:268-273
31. Rogers J (2000) An IL-1 alpha susceptibility polymorphism in Alzheimer's disease: new fuel for the inflammation hypothesis. Neurology 55:464
32. Schaeffer AJ, Landis JR, Knauss JS, Propert KJ, Alexander RB, Litwin MS, Nickel JC, O'Leary MP, Nadler RB, Pontari MA, Shoskes DA, Zeitlin SI, Fowler JE, Mazurick CA, Kishel L, Kusek JW, Nyberg LM, CPCRN (2002) Demographic and clinical characteristics of men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study. J Urol 168:593-598
33. Schaeffer AJ, Knauss JS, Landis JR, Propert KJ, Alexander RB, Litwin MS, Nickel JC, O'Leary MP, Nadler RB, Pontari MA, Shoskes DA, Zeitlin SI, Fowler JE, Mazurick CA, Kusek JW, Nyberg LM, Chronic Prostatitis Collaborative Research Network (2002) Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study. J Urol 168:1048-1053
34. Shahed AR, Shoskes DA (2001) Correlation of [beta]-endorphin and prostaglandin E2 levels in prostatic fluid of patients with chronic prostatitis with diagnosis and treatment response. J Urol 166:1738-1741
35. Shoskes DA, Albakri Q, Thomas K, Cook D (2002) Cytokine polymorphisms in men with chronic prostatitis/chronic pelvic pain syndrome: association with diagnosis and treatment response. J Urol 168:331-335
36. True LD, Berger RE, Rothman I, Ross SO, Krieger JN (1999) Prostate histopathology and the chronic prostatitis/chronic pelvic pain syndrome: a prospective biopsy study. J Urol 162:2014-2018
37. Wenninger K, Heiman JR, Rothman I, Berghuis JP, Berger RE (1996) Sickness impact of chronic nonbacterial prostatitis and its correlates. J Urol 155:965-968
38. Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12:121-127